JW (Cayman) Therapeutics Co. Ltd (HKG:2126)
Hong Kong
· Delayed Price · Currency is HKD 2.910
-0.040 (-1.36%)
Jul 4, 2025, 4:08 PM HKT
HKG:2126 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Net Income | -590.62 | -768 | -846.14 | -702.33 | -1,664 | Upgrade
|
Depreciation & Amortization | 83.67 | 93.77 | 81.37 | 46.33 | 23.17 | Upgrade
|
Other Amortization | 5.99 | 6.06 | 5.71 | 1.9 | 0.42 | Upgrade
|
Loss (Gain) From Sale of Assets | - | 0.93 | 0.17 | 0.12 | - | Upgrade
|
Asset Writedown & Restructuring Costs | 132.26 | 181.21 | - | - | - | Upgrade
|
Stock-Based Compensation | 37.31 | 34.97 | 82.5 | 89.37 | 134.25 | Upgrade
|
Other Operating Activities | 27.77 | 49.45 | 164.76 | -46.37 | 1,228 | Upgrade
|
Change in Accounts Receivable | -35.22 | -36.64 | -5.31 | - | - | Upgrade
|
Change in Inventory | 3.52 | 5.38 | -8.76 | -28.78 | -0.96 | Upgrade
|
Change in Unearned Revenue | -14.22 | 30.42 | - | - | - | Upgrade
|
Change in Other Net Operating Assets | 16.1 | 4.02 | -11.03 | 78.57 | 17.63 | Upgrade
|
Operating Cash Flow | -333.44 | -398.42 | -536.72 | -561.2 | -261.01 | Upgrade
|
Capital Expenditures | -5.22 | -12.41 | -76.87 | -73.09 | -124.24 | Upgrade
|
Sale of Property, Plant & Equipment | - | 0.08 | 0.05 | - | - | Upgrade
|
Cash Acquisitions | - | - | - | - | 45.31 | Upgrade
|
Sale (Purchase) of Intangibles | -10.15 | -2.17 | -23.71 | -64.04 | -12.98 | Upgrade
|
Other Investing Activities | -0.06 | 24.4 | -23.55 | - | - | Upgrade
|
Investing Cash Flow | -15.43 | 9.9 | -124.08 | -137.13 | -91.91 | Upgrade
|
Long-Term Debt Issued | 327.95 | 210 | 234.8 | - | 49.18 | Upgrade
|
Long-Term Debt Repaid | -225.71 | -197.34 | -115.75 | -13.02 | -11.8 | Upgrade
|
Net Debt Issued (Repaid) | 102.24 | 12.66 | 119.05 | -13.02 | 37.38 | Upgrade
|
Issuance of Common Stock | 0.4 | 0.03 | 0.09 | 0.7 | 2,140 | Upgrade
|
Other Financing Activities | -12.16 | -12.42 | -6.79 | -18.3 | -27.3 | Upgrade
|
Financing Cash Flow | 90.49 | 0.28 | 112.35 | -30.62 | 2,859 | Upgrade
|
Foreign Exchange Rate Adjustments | 9.84 | 10.81 | 97.39 | -67.25 | -130.78 | Upgrade
|
Net Cash Flow | -248.53 | -377.43 | -451.06 | -796.2 | 2,376 | Upgrade
|
Free Cash Flow | -338.67 | -410.83 | -613.6 | -634.29 | -385.24 | Upgrade
|
Free Cash Flow Margin | -214.05% | -236.30% | -421.13% | -2059.57% | - | Upgrade
|
Free Cash Flow Per Share | -0.82 | -1.00 | -1.50 | -1.59 | -2.92 | Upgrade
|
Cash Interest Paid | 12.16 | 12.42 | 6.79 | 5.91 | 5.24 | Upgrade
|
Levered Free Cash Flow | -227.7 | -218.11 | -428.1 | -575.04 | -168.34 | Upgrade
|
Unlevered Free Cash Flow | -220.06 | -210.35 | -423.86 | -573.36 | -167.86 | Upgrade
|
Change in Net Working Capital | 44.77 | -25.78 | 57.12 | 91.5 | -103.93 | Upgrade
|
Updated Sep 26, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.